首页> 外国专利> METHOD FOR IDENTIFYING PHARMACEUTICALLY ACTIVE COMPOUND FOR TREATMENT OF CONDITION CAUSED BY ALTERED EXPRESSION OF INSULIN RECEPTOR

METHOD FOR IDENTIFYING PHARMACEUTICALLY ACTIVE COMPOUND FOR TREATMENT OF CONDITION CAUSED BY ALTERED EXPRESSION OF INSULIN RECEPTOR

机译:鉴定用于治疗胰岛素受体改变表达所致病症的药物活性化合物的方法

摘要

PPROBLEM TO BE SOLVED: To provide a reliable screening method for providing methods and pharmaceuticals for treating erectile dysfunction, identifying new compounds useful for treating the erectile dysfunction and evaluating whether the compounds are effective in the treatment of such conditions. PSOLUTION: A kit for identifying a pharmaceutically active compound for treating conditions caused by altered expression of an insulin receptor includes following (a) and (b); (a) a means for in-vitro analysis of the amount of the Ex11SP+/SP-splice variant and/or the Ex11SP-/SP-splice variant of the insulin receptor in a sample derived from the mammal administered with a latent pharmaceutically active compound, and (b) an instruction instructing to select a compound which leads to an increase of the amount of the Ex11SP+/SP-splice variant and/or a decrease of the amount of the Ex11SP-/SP-variant of the insulin receptor. PCOPYRIGHT: (C)2005,JPO&NCIPI
机译:<待解决的问题:提供一种可靠的筛选方法,以提供用于治疗勃起功能障碍的方法和药物,鉴定可用于治疗勃起功能障碍的新化合物,并评估这些化合物是否有效治疗此类疾病。

解决方案:鉴定用于治疗因胰岛素受体表达改变引起的疾病的药物活性化合物的试剂盒,包括(a)和(b); (a)体外分析样品中胰岛素受体的Ex11 + -剪接变体和/或Ex11 --剪接变体的量的手段衍生自施用了潜在药物活性化合物的哺乳动物,以及(b)指示选择一种化合物的说明,该化合物可导致Ex11 + 剪接变体的量增加和/或减少受体的Ex11 --变体的数量。

版权:(C)2005,JPO&NCIPI

著录项

  • 公开/公告号JP2005021165A

    专利类型

  • 公开/公告日2005-01-27

    原文格式PDF

  • 申请/专利权人 SCHERING AG;

    申请/专利号JP20040246014

  • 申请日2004-08-25

  • 分类号C12Q1/68;A61K45/00;A61P15/10;C12N15/09;G01N33/15;G01N33/50;G01N33/53;

  • 国家 JP

  • 入库时间 2022-08-21 22:33:24

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号